Inventor · disambiguated record
Darrell J. Irvine
Also filed as: IRVINE DARRELL · IRVINE DARRELL J
63 granted patents·50 pending applications·590 citations·filing 1999–2025
99Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY90DANA FARBER CANCER INST INC3IRVINE DARRELL J3ANKYRA THERAPEUTICS INC2JANSSEN VACCINES & PREVENTION BV2
Top patents by PatentIndex Score
113 records- 0197US9750803B2Lipid vesicle compositions and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Sep 5, 2017·14 cites·22 claims
- 0297US9445994B2Lipid vesicle compositions and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Sep 20, 2016·24 cites·27 claims
- 0397US8747869B2Lipid vesicle compositions and methods of useIRVINE DARRELL J·Filed 2011·Granted Jun 10, 2014·51 cites·15 claims
- 0496US9907753B2Lipid vesicle compositions and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Mar 6, 2018·8 cites·23 claims
- 0596US9616020B2Lipid vesicle compositions and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Apr 11, 2017·9 cites·26 claims
- 0696US8951542B2Lipid vesicle compositions and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted Feb 10, 2015·15 cites·20 claims
- 0796US6207749B1Comb copolymers for regulating cell-surface interactionsMASSACHUSETTS INST TECHNOLOGY·Filed 2000·Granted Mar 27, 2001·101 cites·16 claims
- 0895US9339462B2Lipid vesicle compositions and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted May 17, 2016·12 cites·27 claims
- 0995US8288159B2Artificial immune system: methods for making and useWARREN WILLIAM L·Filed 2010·Granted Oct 16, 2012·32 cites·30 claims
- 1094US10953105B2Immunostimulatory compositions and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Mar 23, 2021·5 cites·25 claims
- 1194US10029016B2Immunostimulatory compositions and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Jul 24, 2018·15 cites·36 claims
- 1294US9393199B2Methods and compositions for localized agent deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Jul 19, 2016·15 cites·66 claims
- 1394US9149432B2Lipid vesicle compositions and methods of useIRVINE DARRELL J·Filed 2012·Granted Oct 6, 2015·14 cites·16 claims
- 1493US11111472B2Delivery of biomolecules to immune cellsMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Sep 7, 2021·19 cites·145 claims
- 1593US9107904B2Immunostimulatory compositions and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Aug 18, 2015·16 cites·26 claims
- 1693US6150459AComb polymers for regulating cell surface interactionsMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Nov 21, 2000·108 cites·20 claims
- 1792US9603944B2Carrier-free biologically-active protein nanostructuresMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted Mar 28, 2017·13 cites·43 claims
- 1891US11448643B2Methods to specifically profile protease activity at lymph nodesMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Sep 20, 2022·5 cites·16 claims
- 1991US11261226B2Cell surface coupling of nanoparticlesMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Mar 1, 2022·2 cites·20 claims
- 2091US10226510B2Carrier-free biologically-active protein nanostructuresMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Mar 12, 2019·8 cites·107 claims
- 2191US9283184B2Methods and compositions for localized agent deliveryIRVINE DARRELL J·Filed 2009·Granted Mar 15, 2016·14 cites·25 claims
- 2290US11419932B2Nucleic acid nanostructure platform for antigen presentation and vaccine formulations formed therefromMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Aug 23, 2022·6 cites·38 claims
- 2390US11034752B2Cell surface coupling of nanoparticlesMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Jun 15, 2021·5 cites·22 claims
- 2490US10357544B2Carrier-free biologically-active protein nanostructuresMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Jul 23, 2019·6 cites·20 claims
- 2590US6399700B2Comb copolymers for regulating cell-surface interactionsMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Jun 4, 2002·27 cites·21 claims
- 2689US12246097B2Nanoparticle vaccine adjuvant and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Granted Mar 11, 2025·1 cites·20 claims
- 2789US10588942B2Carrier-free biologically-active protein nanostructuresMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Mar 17, 2020·5 cites·20 claims
- 2889US7855074B2Artificial immune system: methods for making and useVAXDESIGN CORP·Filed 2005·Granted Dec 21, 2010·13 cites·46 claims
- 2986US8030070B2Artificial lymphoid tissue equivalentSANOFI PASTEUR VAXDESIGN CORP·Filed 2006·Granted Oct 4, 2011·4 cites·18 claims
- 3085US10888603B2Methods of treating cancer cells expressing tumor-associated integrinsMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Jan 12, 2021·4 cites·35 claims
- 3183US12383589B2Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Granted Aug 12, 2025·0 cites·19 claims
- 3283US9610252B2Multilayer compositions, coated devices and use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Apr 4, 2017·4 cites·29 claims
- 3382US2023277626A1Carrier-free biologically-active protein nanostructuresMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Application pending·0 cites
- 3481US12433946B2Immunomodulatory fusion protein-metal hydroxide complexes and methods thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Granted Oct 7, 2025·0 cites·24 claims
- 3581US11717548B2Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Aug 8, 2023·1 cites·22 claims
- 3681US11077199B2Albumin binding peptide conjugates and methods thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Aug 3, 2021·1 cites·24 claims
- 3781US9415070B2Methods and compositions for localized delivery of agents to virally infected cells and tissuesMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Aug 16, 2016·2 cites·20 claims
- 3880US11547672B2Nanoparticle vaccine adjuvant and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Jan 10, 2023·1 cites·40 claims
- 3980US11026894B2Lipid nanoparticles and use thereof to deliver RNA polynucleotidesMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Jun 8, 2021·1 cites·21 claims
- 4078US11235051B2Methods and compositions for heterologous repRNA immunizationsJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Feb 1, 2022·1 cites·21 claims
- 4176US12303566B2Immunostimulatory compositions and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted May 20, 2025·0 cites·21 claims
- 4276US9625444B2Artificial immune system: methods of useSANOFI PASTEUR VAXDESIGN CORP·Filed 2014·Granted Apr 18, 2017·1 cites·23 claims
- 4375US11351271B2RNA-based logic circuits with RNA binding proteins, aptamers and small moleculesMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Jun 7, 2022·2 cites·15 claims
- 4474US10300145B2Synthetic nanoparticles for delivery of immunomodulatory compoundsMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted May 28, 2019·1 cites·19 claims
- 4574US2025195674A1Immunostimulatory compositions and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2025·Application pending·0 cites
- 4674US2023248840A1Albumin binding peptide conjugates and methods thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Application pending·0 cites
- 4773US11419947B2Layer-by-layer nanoparticles for cytokine therapy in cancer treatmentMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Aug 23, 2022·2 cites·20 claims
- 4873US8722402B2Artificial immune system: methods of useWARREN WILLIAM L·Filed 2012·Granted May 13, 2014·1 cites·30 claims
- 4972US11642416B2Albumin binding peptide conjugates and methods thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted May 9, 2023·0 cites·20 claims
- 5072US2025327085A1Fusion polypeptidesANKYRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 113 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Darrell J. Irvine files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →